Case number IPR2017-01166
Pfizer, Inc. v. Biogen, Inc. > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Apr 21, 2017 | 1 | POA on behalf of Pfizer Inc. Download | |
| Apr 21, 2017 | 2 | PETITION FOR INTER PARTES REVIEW Download | |
| May 15, 2017 | 3 | Notice of Accord Filing Date Download | |
| May 15, 2017 | 4 | Notice of Accord Filing Date Download | |
| May 15, 2017 | 5 | Power of Attorney Download | |
| May 15, 2017 | 6 | Patent Owner's Mandatory Notice Download | |
| Aug 15, 2017 | 7 | Patent Owner's Preliminary Response Download | |
| Aug 15, 2017 | 8 | Patent Owner's Exhibit List Download | |
| Nov 13, 2017 | 9 | Decision - Denying Institution of Inter Partes Review Download | |
| Dec 12, 2017 | 10 | PETITIONER'S REQUEST FOR REHEARING Download | |
| Dec 27, 2017 | 11 | Patent Owner's Updated Mandatory Notice Download | |
| Jan 31, 2018 | 12 | Petitioner's Updated Mandatory Notice Download | |
| Jan 16, 2019 | 13 | DECISION Granting Petitioner’s Request to Withdraw Its Request for Rehearing 37 C.F.R. § 42.71 Download | |
| Jan 17, 2019 | 14 | Motion for Refund of Post-Institution Fee Download | |
| Feb 19, 2019 | 15 | Notice of Refund Download | |
| Apr 21, 2017 | 1001 | Pat No. 8329172 Download | |
| Apr 21, 2017 | 1002 | Declaration of Howard Ozer Download | |
| Apr 21, 2017 | 1003 | McNeil Download | |
| Apr 21, 2017 | 1004 | 1997 Rituxan Label Download | |
| Apr 21, 2017 | 1005 | Hochster I Download | |
| Apr 21, 2017 | 1006 | McLaughlin Download | |
| Apr 21, 2017 | 1007 | Sriskandan Download | |
| Apr 21, 2017 | 1008 | Maloney Download | |
| Apr 21, 2017 | 1009 | Aviles Download | |
| Apr 21, 2017 | 1010 | Steward Download | |
| Apr 21, 2017 | 1011 | Hiddeman II Download | |
| Apr 21, 2017 | 1012 | Unterhalt Download | |
| Apr 21, 2017 | 1013 | Foon Download | |
| Apr 21, 2017 | 1014 | Campbell Download | |
| Apr 21, 2017 | 1015 | Skarin Download | |
| Apr 21, 2017 | 1016 | Scott Bennett Declaration Download | |
| Apr 21, 2017 | 1017 | Hiddemann I. Download | |
| Apr 21, 2017 | 1018 | Bishop Download | |
| Apr 21, 2017 | 1019 | 956 Spec Download | |
| Apr 21, 2017 | 1020 | 180 Provisional Download | |
| Apr 21, 2017 | 1021 | 956 Prelim Amendment Download | |
| Apr 21, 2017 | 1022 | 956 8-25-10 Remarks Download | |
| Apr 21, 2017 | 1023 | 956 Office Action Download | |
| Apr 21, 2017 | 1024 | 956 Notice of Allowance Download | |
| Apr 21, 2017 | 1025 | Portlock Download | |
| Apr 21, 2017 | 1026 | Hoppe Download | |
| Apr 21, 2017 | 1027 | 956 10-28-11 Remarks Download | |
| Apr 21, 2017 | 1028 | Mark Benyunes Declaration Download | |
| Apr 21, 2017 | 1029 | Hochster II Download | |
| Apr 21, 2017 | 1030 | IPR2015-00418 Prelim Resp Download | |
| Apr 21, 2017 | 1031 | IPR2015-00418 Institution Denied Download | |
| Apr 21, 2017 | 1032 | Current Rituxan Label Download | |
| Apr 21, 2017 | 1033 | Dana Download | |
| Apr 21, 2017 | 1034 | Solal Download | |
| Apr 21, 2017 | 1035 | Wadler Download | |
| Apr 21, 2017 | 1036 | Feugier Download | |
| Apr 21, 2017 | 1037 | Habermann Download | |
| Apr 21, 2017 | 1038 | DeNardo Download | |
| Apr 21, 2017 | 1039 | Rituxan 1999 PDR Download | |
| Apr 21, 2017 | 1040 | Pat No. 5736137 Download | |
| Aug 15, 2017 | 2001 | Ex 2001 Non-Institution Decision in IPR2015-00418 Download | |
| Aug 15, 2017 | 2002 | Ex 2002 Ad-Ismail, Combinations Chemotherapy including Epirubicin Download | |
| Aug 15, 2017 | 2003 | Ex 2003 Hiddemann, Non-Hodgkin's Lymphomas Download | |
| Aug 15, 2017 | 2004 | Ex 2004 Vose, Diagnosis and Treatment of Non-Hodgkin's Lymphoma of Adults Download | |
| Aug 15, 2017 | 2005 | Ex 2005 Restriction Requirement dated Oct. 15, 2009 Download | |
| Aug 15, 2017 | 2006 | Ex 2006 Applicant's Election dated Jan. 29, 2010 Download | |
| Aug 15, 2017 | 2009 | Schein, Non-Hodgkin's Lymphoma: Patterns of Relapse from Complete Remission Download | |
| Aug 15, 2017 | 2010 | Ex 2010 Cabanillas, Clinical, Biologic, and Histologic Features of Late Relapses Download | |
| Aug 15, 2017 | 2012 | Ex 2012 Ezdinli, The Effect of Intensive Intermittent Maintenance Therapy Download | |
| Aug 15, 2017 | 2013 | Ex 2013 Van Oers, Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin's Lymphoma Download | |
| Aug 15, 2017 | 2015 | Ex 2015 Arranz, Role of Interferon Alfa-2b in the Induction and Maintenance Treatment of Low-Grade Non-Hodgkin's Lymphoma Download | |
| Aug 15, 2017 | 2016 | Ex 2016 Dana, A Randomized Study of Alpha-Interferon Consolidation Download | |
| Aug 15, 2017 | 2017 | Ex 2017 Peterson, Cyclophosphamide vs Cyclophosphamide Plus Interferon Alfa-2b Download | |
| Aug 15, 2017 | 2018 | Ex 2018 Chisesi, Randomized Study of Chlorambucil Download | |
| Aug 15, 2017 | 2019 | Ex 2019 Rohatiner, Meta-Analysis to Evaluate the Role of Interferon Download | |
| Aug 15, 2017 | 2020 | Ex 2020 Davis, Therapy of B Cell Lymphoma with anti-CD20 antibodies Download | |
| Aug 15, 2017 | 2021 | Ex 2021 Multani, Monoclonal Antibody-Based Therapies Download | |
| Aug 15, 2017 | 2023 | Ex 2023 Carlson, Rituximab plus CHOP Download | |
| Aug 15, 2017 | 2025 | Ex 2025 Czuczman, Chemoimmunotherapy of Low-Grade Lymphoma Download | |
| Aug 15, 2017 | 2026 | Ex 2026 Grossbard, American Cancer Society Atlas of Clinical Oncology Download | |
| Aug 15, 2017 | 2027 | Ex 2027 Aviles, The Role of Interferon as Maintenance Therapy in Malignant Lymphoma Download | |
| Aug 15, 2017 | 2029 | Ex 2029 Grillo-Lopez, Treatment Options for Patients with Relapsed Low-Grade Follicular Lymphoma Download | |
| Aug 15, 2017 | 2030 | Ex 2030 Pickup, Clinical Pharmacokinetics of Prednisone and Prednisolone Download | |
| Aug 15, 2017 | 2031 | Ex 2031 Martelli, Current Guidelines for the Management of Aggressive Non-Hodgkin's Lymphoma Download | |
| Aug 15, 2017 | 2032 | Ex 2032 Meyer, Phase I Trial of Standard and Cyclophosphamide Dose-Escalated CHOP Download | |
| Aug 15, 2017 | 2033 | Ex 2033 Janeway, Chapter 9:The Humoral Immune Response Download | |
| Aug 15, 2017 | 2034 | Ex 2034 Maloney, Phase I Clinical Trial sing Escalating Single-Dose Infusion of Chimeric Anti-CD20 Monoclonal Antibody Download | |
| Aug 15, 2017 | 2035 | Ex 2035 Horning, Treatment Approaches to the Low-Grade Lymphomas Download | |
| Aug 15, 2017 | 2036 | Ex 2036 Chen, Synergistic Anti-proliferative Effect of Metformin and Sorafenib on Growth of Anaplastic Thyroid Cancer Cell Download | |
| Aug 15, 2017 | 2037 | Ex 2037 Dudeja, Synergy of Water Soluble Prodrug Triptolide Download | |
| Aug 15, 2017 | 2038 | Ex 2038 Understanding Maintenance Therapy Download | |
| Aug 15, 2017 | 2039 | Ex 2039 Grossbard, The McLaughlin Article Reviewed Download | |
| Aug 15, 2017 | 2040 | Ex 2040 Wang, The Synergistic In Vitro and In Vivo Antitumor Effect of Combination Therapy Download | |
| Aug 15, 2017 | 2041 | Ex 2041 Excerpts from Physicians' Desk Reference, Edition 52 Download | |
| Aug 15, 2017 | 2042 | Ex 2042 Song Declaration Download | |
| Jan 16, 2019 | 3001 | Exhibit 3001 Download |
